ReviewBioscience reports2022
Current progress of immune checkpoint inhibitors in the treatment of advanced hepatocellular carcinoma.
Xiaoqiang Yin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
12 papers cite it
this paperpooled itcites it